20 October 2023
Cancers | Most Viewed Special Issues in 2023 in the Section “Cancer Immunology and Immunotherapy”


We are pleased to invite you to read the most viewed Special Issues in 2023 in Cancers (ISSN: 2072-6694) in the Section “Cancer Immunology and Immunotherapy”. The Special Issues list is as follows:

“Targeted Treatment and Immunotherapy for Hepato-Biliary Tumors
Edited by Dr. Girolamo Ranieri and Dr. Carmelo Laface
Views: 10000+ times

PD-1/PD-L1 Immune Checkpoint Therapy: From Predictive Biomarkers to Noninvasive Imaging
Edited by Prof. Dr. Patrizia Ferroni, Prof. Dr. Fiorella Guadagni and Prof. Dr. Mario Roselli
Views: 10000+ times

Mechanisms of Immunosuppression in Cancer
Edited by Dr. Shweta Joshi
Views: 8300+ times

Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma
Edited by Dr. Thierry Massfelder, Dr. Philippe Barthélémy, Dr. Valerian Dormoy and Dr. Mamatha Garige
Views: 7200+ times

B Cells and Antibodies in Immune Surveillance and Therapy for Cancer
Edited by Prof. Dr. Sophia Karagiannis, Dr. Joseph G Crompton
Views: 4300+ times

Anti-tumor Immune Responses: Mechanisms and Escape Mechanisms
Edited by Prof. Dr. Jürgen C. Becker, Dr. Weng-Onn Lui
Views: 3400+ times

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

Back to TopTop